2,851
edits
Dr. David Sinclair: Difference between revisions
→References
| Line 114: | Line 114: | ||
|Lifespan: Why We Age – and Why We Don’t Have To | |Lifespan: Why We Age – and Why We Don’t Have To | ||
|Sept. 2019 | |Sept. 2019 | ||
| | |X | ||
| | |X | ||
| | |X | ||
| | | | ||
| | | | ||
| | | | ||
| | |X | ||
| | |X | ||
| | | | ||
| | |X | ||
| | | | ||
| | | | ||
| Line 137: | Line 137: | ||
|[[2021-12-27 - Interview Dr. David Sinclair - Huberman Lab Podcast - The Biology of Slowing & Reversing Aging]] | |[[2021-12-27 - Interview Dr. David Sinclair - Huberman Lab Podcast - The Biology of Slowing & Reversing Aging]] | ||
|Dec 2021 | |Dec 2021 | ||
| | |X | ||
| | |X | ||
|M | |M | ||
| | | | ||
| Line 151: | Line 151: | ||
| | | | ||
| | | | ||
| | |X | ||
| | | | ||
| | | | ||
| Line 160: | Line 160: | ||
|[[2022-01-26 - Podcast Dr. David Sinclair - NMN, NR, Resveratrol, Metformin & Other Longevity Molecules]] | |[[2022-01-26 - Podcast Dr. David Sinclair - NMN, NR, Resveratrol, Metformin & Other Longevity Molecules]] | ||
|Jan 2022 | |Jan 2022 | ||
| | |X | ||
| | |X | ||
|N | |N | ||
| | |X | ||
| | |X | ||
| | |X | ||
| | | | ||
| | | | ||
| Line 197: | Line 197: | ||
| | | | ||
| | | | ||
| | |X | ||
| | | | ||
| | | | ||
| Line 206: | Line 206: | ||
|[[2022-08-30 - Interview Dr. David Sinclair - Optimize Longevity - What To Eat & When For Longevity]] | |[[2022-08-30 - Interview Dr. David Sinclair - Optimize Longevity - What To Eat & When For Longevity]] | ||
|Aug 2022 | |Aug 2022 | ||
| | |X | ||
| | |X | ||
| | |X | ||
| | | | ||
| | | | ||
| | | | ||
| | |X | ||
| | |X | ||
| | |X | ||
|N | |N | ||
| | | | ||
|N | |N | ||
| | |X | ||
|N | |N | ||
| | | | ||
| | |X | ||
| | |X | ||
| | | | ||
| | | | ||
| Line 229: | Line 229: | ||
|[[2022-08-31 - Interview Dr. David Sinclair - Optimize Longevity - Longevity Molecules and Supplements]] | |[[2022-08-31 - Interview Dr. David Sinclair - Optimize Longevity - Longevity Molecules and Supplements]] | ||
|Aug 2022 | |Aug 2022 | ||
| | |X | ||
| | |X | ||
| | |X | ||
| | |X | ||
|T | |T | ||
|T | |T | ||
| Line 263: | Line 263: | ||
| | | | ||
| | | | ||
| | |X | ||
| | | | ||
| | |X | ||
| | | | ||
| | |X | ||
| | | | ||
|N | |N | ||